Amgen NSCLC Data Could Give Lumakras Boost As Competition Looms

 
• By Alaric DeArment
  
Amgen announced longer-term data for Lumakras in NSCLC • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D